Natural α,β-unsaturated lactones inhibit neuropeptide-induced mast cell activation in an in vitro model of neurogenic inflammation
Autor: | Roberto Carlos Coll, Alicia B. Penissi, María Laura Mariani, Patricia María Vargas |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Ketotifen Serotonin Immunology Neuropeptide Substance P Pharmacology Lactones 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine medicine Animals Mast Cells Rats Wistar Cells Cultured Neurotensin Neurogenic inflammation Chemistry Degranulation Mast cell Peptide Fragments In vitro 030104 developmental biology medicine.anatomical_structure 030220 oncology & carcinogenesis Neurogenic Inflammation medicine.drug |
Zdroj: | Inflammation Research. 69:1039-1051 |
ISSN: | 1420-908X 1023-3830 |
DOI: | 10.1007/s00011-020-01380-8 |
Popis: | Mast cells are involved in not only inducing, but also maintaining neurogenic inflammation and neuropathic pain. In previous work, we have demonstrated that dehydroleucodine, xanthatin and 3-benzyloxymethyl-5H-furan-2-one inhibit rat peritoneal and human LAD2 mast cell degranulation induced by compound 48/80 and calcium ionophore A23187. However, the effect of these molecules on neuropeptide-induced mast cell activation has not been studied so far. The aim of this study was to determine whether dehydroleucodine, xanthatin, and 3-benzyloxymethyl-5H-furan-2-one inhibit neuropeptide-induced mast cell activation. This work is based on in vitro simulation of a neurogenic inflammation scenario involving neuropeptides and mast cells, to subsequently analyze potential therapeutic strategies for neuropathic pain. Neuromedin-N did not stimulate mast cell serotonin release but substance P and neurotensin did induce serotonin release from peritoneal mast cells in a dose-dependent manner. Mast cell serotonin release induced by substance P and neurotensin was inhibited by dehydroleucodine and xanthatin, but not by 3-benzyloxymethyl-5H-furan-2-one. The inhibitory potency of dehydroleucodine and xanthatin was higher than that obtained with the reference compounds, ketotifen and sodium chromoglycate, when mast cells were preincubated with dehydroleucodine before substance P incubation, and with dehydroleucodine or xanthatin before neurotensin incubation. These results are the first strong evidence supporting the hypothesis that dehydroleucodine and xanthatin inhibit substance P- and neurotensin-induced serotonin release from rat peritoneal mast cells. Our findings suggest, additionally, that these α,β-unsaturated lactones could be of value in future pharmacological research related to inappropriate mast cell activation conditions such as neurogenic inflammation and neuropathic pain. |
Databáze: | OpenAIRE |
Externí odkaz: |